stopped semaglutide for a month Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema stopped semaglutide for a month

Were passionate about providing the support and treatments you need to succeed

But if youre part of a monitored peptide consultation programme, this is something to track

This will lead either to a lack of treatment, higher side effects, or even toxicity from overdosing on the wrong active ingredients or side active ingredients

Key differences at a glance Understanding GLP-1 medications GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes but have revolutionised obesity treatment

For example, specific GLP1R variants are associated with stronger appetite suppression in some individuals, while FTO variants correlate with baseline metabolic flexibility